MTOR and mitochondrial disease: In this study, we found that inactivation of the mTOR substrate S6K1 in the whole body modestly enhances survival and delays the onset of a characteristic neurological symptom in the NKO mouse model of severe mitochondrial disease resulting from Complex I deficiency.